Iron Status and Survival in Diabetic Patients With Coronary Artery Disease

OBJECTIVE To investigate the impact of iron status on survival in patients with type 2 diabetes and coronary artery disease (CAD). RESEARCH DESIGN AND METHODS Serum ferritin, transferrin saturation (Tsat), and soluble transferrin receptor (sTfR) were measured in 287 patients with type 2 diabetes and stable CAD (65 ± 9 years of age, 78% men). RESULTS During a mean follow-up of 45 ± 19 months, there were 59 (21%) deaths and 60 (21%) cardiovascular hospitalizations. Both serum ferritin and sTfR strongly predicted 5-year all-cause mortality rates, independently of other variables (including hemoglobin, measures of renal function, inflammation, and neurohormonal activation). There was an exponential relationship between sTfR and mortality (adjusted hazard ratio [HR] per 1 log mg/L: 4.24 [95% CI 1.43–12.58], P = 0.01), whereas the relationship between ferritin and mortality was U-shaped (for the lowest and the highest quintiles vs. the middle quintile [reference group], respectively: adjusted HR 7.18 [95% CI 2.03–25.46], P = 0.002, and adjusted HR 5.12 [1.48–17.73], P = 0.01). Similar patterns were observed for the composite outcome of all-cause mortality or cardiovascular hospitalization, and in these multivariable models, low Tsat was related to unfavorable outcome. CONCLUSIONS Both low and high serum ferritin (possibly reflecting depleted and excessive iron stores, respectively) along with high serum sTfR (reflecting reduced metabolically available iron) identify patients with type 2 diabetes and CAD who have a poor prognosis.

[1]  R Core Team,et al.  R: A language and environment for statistical computing. , 2014 .

[2]  Kuo-Chin Huang,et al.  Iron deficiency is associated with increased risk for cardiovascular disease and all-cause mortality in the elderly living in long-term care facilities. , 2013, Nutrition.

[3]  P. Ponikowski,et al.  Iron deficiency in chronic heart failure: an international pooled analysis. , 2013, American heart journal.

[4]  P. Ponikowski,et al.  Iron status in patients with chronic heart failure. , 2013, European heart journal.

[5]  Dylan L. Steen,et al.  Prognostic Evaluation of Catalytic Iron in Patients With Acute Coronary Syndromes , 2013, Clinical cardiology.

[6]  D. Niederseer,et al.  Iron homeostasis in the Metabolic Syndrome , 2013, European journal of clinical investigation.

[7]  P. Ponikowski,et al.  Iron deficiency and heart failure: diagnostic dilemmas and therapeutic perspectives , 2012, European heart journal.

[8]  Hiroyasu 博康 Iso 磯,et al.  Associations of Dietary Iron Intake With Mortality From Cardiovascular Disease: The JACC Study , 2012, Journal of epidemiology.

[9]  B. Paw,et al.  Cellular and mitochondrial iron homeostasis in vertebrates. , 2012, Biochimica et biophysica acta.

[10]  Ning Li,et al.  Mitochondrial dysfunction in pancreatic β cells , 2012, Trends in Endocrinology & Metabolism.

[11]  E. Guallar,et al.  The association of biomarkers of iron status with mortality in US adults. , 2012, Nutrition, metabolism, and cardiovascular diseases : NMCD.

[12]  D. Lee,et al.  Associations of Serum Ferritin and Transferrin % Saturation With All-cause, Cancer, and Cardiovascular Disease Mortality: Third National Health and Nutrition Examination Survey Follow-up Study , 2012, Journal of preventive medicine and public health = Yebang Uihakhoe chi.

[13]  D. Bhat,et al.  Spuriously High Prevalence of Prediabetes Diagnosed by HbA1c in Young Indians Partly Explained by Hematological Factors and Iron Deficiency Anemia , 2012, Diabetes Care.

[14]  Elizabeta Nemeth,et al.  Rethinking iron regulation and assessment in iron deficiency, anemia of chronic disease, and obesity: introducing hepcidin. , 2012, Journal of the Academy of Nutrition and Dietetics.

[15]  M. Roden,et al.  The role of mitochondria in insulin resistance and type 2 diabetes mellitus , 2012, Nature Reviews Endocrinology.

[16]  M. Mazzali,et al.  Anemia in chronic renal disease: evaluation of inflammatory activity on erythropoiesis and iron metabolism in patients not submitted to dialysis treatment. , 2012, Clinical laboratory.

[17]  P. Ponikowski,et al.  Iron deficiency predicts impaired exercise capacity in patients with systolic chronic heart failure. , 2011, Journal of cardiac failure.

[18]  V. Tikhonoff,et al.  Dietary iron intake and cardiovascular outcome in Italian women: 10-year follow-up. , 2011, Journal of women's health.

[19]  L. Vatten,et al.  Mortality from ischaemic heart disease: sex-specific effects of transferrin saturation, serum iron, and total iron binding capacity. The HUNT study , 2011, European journal of cardiovascular prevention and rehabilitation : official journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology.

[20]  L. Hancock.  7. Anker SD, Comin Colet J, Filippatos G, et al; FAIR-HF Trial Investigators. Ferric carboxymaltose in patients with heart failure and iron deficiency. N Engl J Med , 2011 .

[21]  T. Ganz,et al.  Detection, evaluation, and management of iron-restricted erythropoiesis. , 2010, Blood.

[22]  P. Ponikowski,et al.  Iron deficiency: an ominous sign in patients with systolic chronic heart failure. , 2010, European heart journal.

[23]  Matthias W. Hentze,et al.  Two to Tango: Regulation of Mammalian Iron Metabolism , 2010, Cell.

[24]  G. Vetrovec,et al.  Iron deficiency anemia and cardiac mortality in patients with left ventricular systolic dysfunction undergoing coronary stenting. , 2010, Minerva cardioangiologica.

[25]  V. Preedy,et al.  National Health and Nutrition Examination Survey , 2010 .

[26]  K. Kowdley,et al.  Hereditary hemochromatosis and diabetes mellitus: implications for clinical practice , 2010, Nature Reviews Endocrinology.

[27]  M. Koga,et al.  A1C but Not Serum Glycated Albumin Is Elevated Because of Iron Deficiency in Late Pregnancy in Diabetic Women , 2009, Diabetes Care.

[28]  P. Ponikowski,et al.  Ferric carboxymaltose in patients with heart failure and iron deficiency. , 2009, The New England journal of medicine.

[29]  Anastasios Koulaouzidis,et al.  Soluble transferrin receptors and iron deficiency, a step beyond ferritin. A systematic review. , 2009, Journal of gastrointestinal and liver diseases : JGLD.

[30]  J. Sullivan.  Iron in arterial plaque: modifiable risk factor for atherosclerosis. , 2009, Biochimica et biophysica acta.

[31]  Glenn W. Suter,et al.  Model based inference in the life sciences: A primer on evidence, by David R. Anderson , 2009 .

[32]  T. Jørgensen,et al.  Is serum ferritin within the reference range a risk predictor of cardiovascular disease? A population-based, long-term study comprising 2874 subjects , 2009, British Journal of Nutrition.

[33]  B. Skikne.  Serum transferrin receptor , 2008, American journal of hematology.

[34]  D. Kell.  Iron behaving badly: inappropriate iron chelation as a major contributor to the aetiology of vascular and other progressive inflammatory and degenerative diseases , 2008, BMC Medical Genomics.

[35]  V. Felitti,et al.  Screening for hemochromatosis by measuring ferritin levels: a more effective approach. , 2007, Blood.

[36]  P. Ponikowski,et al.  Effect of intravenous iron sucrose on exercise tolerance in anemic and nonanemic patients with symptomatic chronic heart failure and iron deficiency FERRIC-HF: a randomized, controlled, observer-blinded trial. , 2007, Journal of the American College of Cardiology.

[37]  Richard F Hurrell,et al.  Nutritional iron deficiency , 2007, The Lancet.

[38]  J. Wish.  Assessing iron status: beyond serum ferritin and transferrin saturation. , 2006, Clinical journal of the American Society of Nephrology : CJASN.

[39]  G. Mancia,et al.  Guidelines on the management of stable angina pectoris: executive summary: the task force on the management of stable angina pectoris of the European society of cardiology. , 2006, European heart journal.

[40]  J. Camm,et al.  [Guidelines on the management of stable angina pectoris: executive summary]. , 2006, Giornale italiano di cardiologia.

[41]  T. Rouault,et al.  Iron–sulphur cluster biogenesis and mitochondrial iron homeostasis , 2005, Nature Reviews Molecular Cell Biology.

[42]  J. Levy,et al.  Use and abuse of HOMA modeling. , 2004, Diabetes care.

[43]  B. Wells,et al.  The combined effect of transferrin saturation and low density lipoprotein on mortality. , 2004, Family medicine.

[44]  R. Gray.  Modeling Survival Data: Extending the Cox Model , 2002 .

[45]  B. Ames,et al.  Iron deficiency and iron excess damage mitochondria and mitochondrial DNA in rats , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[46]  H. Schneider,et al.  Serum transferrin receptor. , 2001, American journal of clinical pathology.

[47]  J. Beard,et al.  Iron biology in immune function, muscle metabolism and neuronal functioning. , 2001, The Journal of nutrition.

[48]  J. Haas,et al.  Iron-Deficiency Anemia: Reexamining the Nature and Magnitude of the Public Health Problem Iron Deficiency and Reduced Work Capacity: A Critical Review of the Research to Determine a Causal Relationship 1,2 , 2001 .

[49]  R. Gillum,et al.  Serum ferritin and death from all causes and cardiovascular disease: the NHANES II mortality study. , 2000 .

[50]  D. McGee,et al.  Serum ferritin and death from all causes and cardiovascular disease: the NHANES II Mortality Study. National Health and Nutrition Examination Study. , 2000, Annals of epidemiology.

[51]  A. Levey,et al.  A More Accurate Method To Estimate Glomerular Filtration Rate from Serum Creatinine: A New Prediction Equation , 1999, Annals of Internal Medicine.

[52]  L. Ferrucci,et al.  Serum iron level, coronary artery disease, and all-cause mortality in older men and women. , 1997, The American journal of cardiology.

[53]  R. Gillum,et al.  Serum transferrin saturation, stroke incidence, and mortality in women and men. The NHANES I Epidemiologic Followup Study. National Health and Nutrition Examination Survey. , 1996, American journal of epidemiology.

[54]  A. Reunanen,et al.  Body iron stores, dietary iron intake and coronary heart disease mortality , 1995, Journal of internal medicine.

[55]  E. Feskens,et al.  Body iron stores and mortality due to cancer and ischaemic heart disease: a 17-year follow-up study of elderly men and women. , 1995, International journal of epidemiology.

[56]  D. Williamson,et al.  Body iron stores and the risk of coronary heart disease. , 1994, The New England journal of medicine.

[57]  E. Beutner,et al.  Report of a WHO Scientific Group (Part 3 of 3) , 1973 .

[58]  B. Blanc.  Nutritional anemias. Report of a WHO Scientific Group , 1968 .